Dianthus Therapeutics, Inc. (DNTH)
41.43
+0.03
(+0.07%)
USD |
NASDAQ |
Dec 17, 16:00
41.42
-0.01
(-0.02%)
After-Hours: 20:00
Dianthus Therapeutics Shareholders Equity (Quarterly): 546.45M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytokinetics, Inc. | -521.12M |
| Lexicon Pharmaceuticals, Inc. | 120.16M |
| Day One Biopharmaceuticals, Inc. | 450.87M |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 577.44M |
| Total Liabilities (Quarterly) | 30.99M |
| Debt to Equity Ratio | 0.0024 |
| Current Ratio | 17.35 |
| Net Debt Paydown Yield | -0.01% |